Michel Azizi (born april 4, 1958) is Professor of Vascular Medicine at Université Paris Cité and Head of the Hypertension Excellence Cente , Georges Pompidou University Hospital, Paris, France. He received his MD from René Descartes University and his PhD from Pierre et Marie Curie University, Paris, France. He is past Vice-President of the European Society of Hypertension (ESH) and past President of the ESH-WG on adherence, pharmacotherapy and lifestyle. His main research interests include the medication- and device-based treatment of resistant hypertension, adherence to treatment and the physiology, genetics and pharmacology of the RAAS. He has published more than 320 papers on his research topics in peer reviewed journals. He has received the Jean Hamburger award (2007), the Peter van Zwieten award (ESH, 2011), the Paul Milliez award (2017), the National Academy of Medecine award (2022), the Björn Folkow award (ESH 2025). He is member of the National Academy of Medicine since 2025